China Biologic Products Holdings Inc - Company Profile

Powered by

All the data and insights you need on China Biologic Products Holdings Inc in one report.

  • Save hours of research time and resources with
    our up-to-date China Biologic Products Holdings Inc Strategy Report

  • Understand China Biologic Products Holdings Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

China Biologic Products Holdings Inc: Overview

China Biologic Products Holdings Inc (China Biologic) is a biopharmaceutical company that focuses on research and development, production, commercialization of plasma-based products. The company’s products find application in medical emergencies and for the treatment and prevention of life threating and immune-deficiency related diseases. The company is also involved in the sales of medical devices, mainly regenerative medical biomaterial products. Few of the products of company include are Human Albumin, Human Hepatitis B Immunoglobulin, Placenta Polypeptide, and Artificial Dura Mater among others. It offers products to hospitals, other healthcare facilities in China and to distributors. China Biologic is headquartered in Beijing, China.

Gain a 360-degree view of China Biologic Products Holdings Inc and make more informed decisions for your business Gain a 360-degree view of China Biologic Products Holdings Inc and make more informed decisions for your business Find out more
Headquarters China

Address 18th Floor, Jialong International Tower, No.19 Chaoyang Park Road, Chaoyang District, Beijing, 100125


Telephone 86 10 65983111

No of Employees 2,269

Industry Pharmaceuticals and Healthcare

Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

China Biologic Products Holdings Inc premium industry data and analytics

14+

Clinical Trials

Determine China Biologic Products Holdings Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

12+

Marketed Drugs

Understand China Biologic Products Holdings Inc’s commercialized product portfolio to stay one step ahead of the market.

6

Sales & Consensus Forecasts

Understand the current and future drug revenue for China Biologic Products Holdings Inc and assess market opportunity for new entrants with patient population 8-year forecasts.

6

Pipeline Drugs

Identify which of China Biologic Products Holdings Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on China Biologic Products Holdings Inc’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products
Human Fibrinogen
Biopharmaceutical
Human Albumin
XYZ
XYZ
XYZ
Understand China Biologic Products Holdings Inc portfolio and identify potential areas for collaboration Understand China Biologic Products Holdings Inc portfolio and identify potential areas for collaboration Find out more
Image for loader

Competitor Comparison

Key Parameters China Biologic Products Holdings Inc Shanghai RAAS Blood Products Co Ltd China Resources Boya Bio-pharmaceutical Group Co Ltd China National Biotec Group Sichuan Yuanda Shuyang Pharmaceutical Co Ltd
Headquarters China China China China China
City Beijing Shanghai Fuzhou Beijing Chengdu
State/Province Beijing Shanghai Jiangxi Beijing Sichuan
No. of Employees 2,269 3,121 1,444 1,000 -
Entity Type Private Public Public Private Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Executives
Name Position Board Since Age
Joseph Chow Chairman; Chief Executive Officer Executive Board 2019 -
Gary Wang Chief Financial Officer; Head - Plasma Collection Management Senior Management - -
Sun Bing General Manager - Taibang TianXinFu Senior Management - -
Yuan Feng Senior Vice President - Commercial Operation General Manager Senior Management - -
Guangli Pang Executive Vice President - Plasma-derived Products Unit Senior Management - -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into China Biologic Products Holdings Inc key executives to enhance your sales strategy Gain insight into China Biologic Products Holdings Inc key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward